Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glutaminase | Starlite/ChEMBL | No references |
Escherichia coli | penicillin-binding protein | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Schistosoma mansoni | glutaminase | Get druggable targets OG5_129245 | All targets in OG5_129245 |
Mycobacterium ulcerans | glutaminase | Get druggable targets OG5_129245 | All targets in OG5_129245 |
Loa Loa (eye worm) | glutaminase 2 | Get druggable targets OG5_129245 | All targets in OG5_129245 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | Get druggable targets OG5_149948 | All targets in OG5_149948 |
Brugia malayi | glutaminase DH11.1 | Get druggable targets OG5_129245 | All targets in OG5_129245 |
Loa Loa (eye worm) | glutaminase | Get druggable targets OG5_129245 | All targets in OG5_129245 |
Trichomonas vaginalis | glutaminase, putative | Get druggable targets OG5_129245 | All targets in OG5_129245 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | beta-LACTamase domain containing family member | 0.0043 | 0.0932 | 0.0932 |
Toxoplasma gondii | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0156 | 0.4483 | 1 |
Brugia malayi | beta-lactamase family protein | 0.0043 | 0.0932 | 0.0295 |
Mycobacterium leprae | PROBABLE THYMIDYLATE SYNTHASE THYA (TS) (TSASE) | 0.0156 | 0.4483 | 1 |
Echinococcus multilocularis | nuclear factor of activated T cells 5 | 0.0071 | 0.1808 | 0.4032 |
Leishmania major | dihydrofolate reductase-thymidylate synthase | 0.0156 | 0.4483 | 1 |
Schistosoma mansoni | chromatin regulatory protein sir2 | 0.0081 | 0.2104 | 0.1549 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription factor | 0.0081 | 0.2123 | 0.4737 |
Echinococcus multilocularis | NAD dependent deacetylase sirtuin 1 | 0.0081 | 0.2104 | 0.4693 |
Echinococcus multilocularis | jun protein | 0.0081 | 0.2123 | 0.4737 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0932 | 0.0932 |
Loa Loa (eye worm) | glutaminase | 0.033 | 1 | 1 |
Trichomonas vaginalis | chromatin regulatory protein sir2, putative | 0.0081 | 0.2104 | 0.1292 |
Brugia malayi | beta-lactamase | 0.0043 | 0.0932 | 0.0295 |
Giardia lamblia | NAD-dependent histone deacetylase Sir2 | 0.0081 | 0.2104 | 0.5 |
Onchocerca volvulus | 0.0156 | 0.4483 | 1 | |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase, putative | 0.0074 | 0.19 | 0.2726 |
Trichomonas vaginalis | chromatin regulatory protein sir2, putative | 0.0081 | 0.2104 | 0.1292 |
Brugia malayi | thymidylate synthase | 0.0156 | 0.4483 | 0.4095 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0932 | 0.0932 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0278 | 0.8344 | 1 |
Mycobacterium ulcerans | glutaminase | 0.033 | 1 | 1 |
Schistosoma mansoni | glutaminase | 0.033 | 1 | 1 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0043 | 0.0932 | 0.0295 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase | 0.0156 | 0.4483 | 1 |
Loa Loa (eye worm) | thymidylate synthase | 0.0156 | 0.4483 | 0.4483 |
Mycobacterium tuberculosis | Hypothetical protein | 0.0074 | 0.19 | 0.1306 |
Echinococcus granulosus | nuclear factor of activated T cells 5 | 0.0071 | 0.1808 | 0.4032 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0932 | 0.0932 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0932 | 0.0932 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0074 | 0.19 | 0.1067 |
Loa Loa (eye worm) | hypothetical protein | 0.007 | 0.1769 | 0.1769 |
Echinococcus multilocularis | thymidylate synthase | 0.0156 | 0.4483 | 1 |
Onchocerca volvulus | 0.0064 | 0.1572 | 0.1802 | |
Brugia malayi | hypothetical protein | 0.0074 | 0.19 | 0.1331 |
Trichomonas vaginalis | glutaminase, putative | 0.033 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0081 | 0.2104 | 0.2104 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.0656 | 0.5 |
Trichomonas vaginalis | chromatin regulatory protein sir2, putative | 0.0081 | 0.2104 | 0.1292 |
Plasmodium falciparum | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0156 | 0.4483 | 0.5 |
Echinococcus granulosus | beta LACTamase domain containing family member | 0.0043 | 0.0932 | 0.208 |
Schistosoma mansoni | hypothetical protein | 0.0066 | 0.1643 | 0.1055 |
Brugia malayi | Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative | 0.0043 | 0.0932 | 0.0295 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0043 | 0.0932 | 0.0295 |
Brugia malayi | beta-lactamase family protein | 0.0043 | 0.0932 | 0.0295 |
Brugia malayi | NAD-dependent deacetylase SIRT1 | 0.0081 | 0.2104 | 0.1549 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0932 | 0.0932 |
Echinococcus granulosus | jun protein | 0.0081 | 0.2123 | 0.4737 |
Mycobacterium ulcerans | thymidylate synthase | 0.0156 | 0.4483 | 0.3915 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0932 | 0.0932 |
Brugia malayi | glutaminase DH11.1 | 0.033 | 1 | 1 |
Trypanosoma brucei | dihydrofolate reductase-thymidylate synthase | 0.0156 | 0.4483 | 1 |
Schistosoma mansoni | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0156 | 0.4483 | 0.4095 |
Loa Loa (eye worm) | hypothetical protein | 0.0079 | 0.2053 | 0.2053 |
Echinococcus granulosus | NAD dependent deacetylase sirtuin 1 | 0.0081 | 0.2104 | 0.4693 |
Trichomonas vaginalis | chromatin regulatory protein sir2, putative | 0.0081 | 0.2104 | 0.1292 |
Brugia malayi | bZIP transcription factor family protein | 0.0081 | 0.2123 | 0.157 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription factor | 0.0081 | 0.2123 | 0.4737 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.0656 | 0.5 |
Echinococcus granulosus | thymidylate synthase | 0.0156 | 0.4483 | 1 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0035 | 0.0656 | 0.1464 |
Brugia malayi | hypothetical protein | 0.0064 | 0.1572 | 0.098 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.0656 | 0.5 |
Loa Loa (eye worm) | beta-lactamase | 0.0043 | 0.0932 | 0.0932 |
Plasmodium vivax | bifunctional dihydrofolate reductase-thymidylate synthase, putative | 0.0156 | 0.4483 | 1 |
Echinococcus multilocularis | beta LACTamase domain containing family member | 0.0043 | 0.0932 | 0.208 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.0656 | 0.5 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0035 | 0.0656 | 0.1464 |
Schistosoma mansoni | jun-related protein | 0.0066 | 0.1643 | 0.1055 |
Mycobacterium tuberculosis | Probable thymidylate synthase ThyA (ts) (TSASE) | 0.0156 | 0.4483 | 0.479 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 0.631 um | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | ChEMBL. | No reference |
Potency (functional) | 6.3096 uM | PubChem BioAssay. qHTS for Inhibitors of Glutaminase (GLS). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.